Top Markets
#1 Siren Siren +33.59%
#2 Wiki Cat Wiki Cat +27.83%
#3 Ribbita by Virtuals Ribbita by Virtuals +17.67%
#4 PulseChain PulseChain +16.92%
#5 Bitway Bitway +16.87%
#6 Velvet Velvet +16.62%
#7 Cysic Cysic +15.53%
#8 TRIA TRIA +15.19%
#9 KUB Coin KUB Coin +14.61%
#10 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +13.76%
Coin of the day
Siren Siren
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
FunPep Company Limited FunPep Company Limited

FunPep Company Limited

4881
Rang in Aktien #30951
FunPep Company Limited specializes in the discovery and advancement of... FunPep Company Limited specializes in the discovery and advancement of pharmaceutical drugs, functional cosmetics, and medical devices, leveraging its core technology in functional peptides. The company's development pipeline prominently features SR-0379, a functional peptide designed to address skin ulcers. FunPep is advancing FPP003, an antibody-inducing peptide, which is undergoing Phase II clinical trials for psoriasis in Australia and for ankylosing spondylitis in Japan. Another antibody-inducing peptide, FPP004X, is also in development, targeting pollinosis. Additionally, the company is working on FPP006, a corona peptide vaccine, and FPP005, an antibody-inducing peptide for psoriasis. Established in 2013, FunPep Company Limited operates from its headquarters in Tokyo, Japan.
Aktienkurs
$0.33274288
Marktkapitalisierung
$14.92M
Veränderung (1 Tag)
2.00%
Veränderung (1 Jahr)
-57.59%
Land
JP
Handel FunPep Company Limited (4881)

Kategorie

Healthcare
P/B-Verhältnis für FunPep Company Limited (4881)
P/B-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von FunPep Company Limited beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/B-Verhältnis bei 0.
P/B-Verlauf für FunPep Company Limited von 2026 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/B-Verhältnis P/B-Verhältnis-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -
BE